Differentiating new marijuana use from residual drug excretion in occasional marijuana users

Journal of Analytical Toxicology

Volumn 22, Issue 6, 1998, Pages 445-454

  Huestis, Marilyn A ^a   Cone, Edward J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; CREATININE; DRONABINOL; WATER;

ACCURACY; ADULT; ARTICLE; CANNABIS ADDICTION; DILUTION; DRUG EXCRETION; DRUG URINE LEVEL; DRUG USE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; URINE VOLUME;

CANNABIS; CANNABIS SATIVA;

EID: 0031666368     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.6.445     Document Type: Article

References (32)

1. D.B. Morgan, S. Dillon, and R.B. Payne. The assessment of glomerular function: creatinine clearance or plasma creatinine? Postgrad. Med. J. 54: 302-310 (1978).
2. K. Spencer. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann. Clin. Biochem. 23: 1-25 (1986).
3. S. Narayanan and H.D. Appleton. Creatinine: a review. Clin. Chem. 26(8): 1119-1126 (1980).
4. M.D.S. Shephard, L.A. Penberthy, and C.G. Fraser. Short- and long-term biological variation in analytes in urine of apparently healthy individuals. Clin. Chem. 27(4): 569-573 (1981).
5. S.A. Bingham and J.H. Cummings. The use of creatinine output as a check on the completeness of 24-hour urine collections. Hum. Nutr.: Clin. Nutr. 39C: 343-355 (1985).
6. L. Alessio, A. Berlin, A. Dell'Orto, F. Toffoletto, and I. Ghezzi. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Inf. Arch. Occup. Environ. Health 55: 99-106 (1985).
7. 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J. Anal. Toxicol. 20: 441-452 (1996).
8. G.M. Ellis, M.A, Mann, B.A. Judson, N.T. Schramm, and A. Tashchian. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin. Pharmacol. Ther. 38: 572-578 (1985).
9. R.L. Hawks. Developments in cannabinoid analyses of body fluids: implications for forensic applications. In The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. S. Agurell, W. Dewey and R. Willette, Eds. Academic Press, Rockville, MD, 1983, pp 1-12.
10. J.E. Manno, K.E. Ferslew, and B.R. Manno. Urine excretion patterns of cannabinoids and the clinical appliation of the EMIT-d.a.u. cannabinoid urine assay for substance abuse treatment. In The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. S. Agurell, W.L. Dewey, and R.E. Willette, Eds. Academic Press, Inc., New York, NY, 1984, pp 281-290.
11. M.A. Huestis, J.M. Mitchell, and E.J. Cone. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J. Anal. Toxicol. 19: 443-149 (1995).
12. B.D. Paul, L.D. Mell, Jr., J.M. Mitchell, R.M. McKinley, and J. Irving. Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography. J. Anal. Toxicol. 11: 1-5 (1987).
13. M.H. Zweig. Assessment of clinical sensitivity and specificity of laboratory tests. National Committee for Clinical Laboratory Standards, GP 10-P. 7(6): 143-171 (1987).
14. V. Spiehler, H. Wilson, S. El Shami, T. Sneath, and N. Jain. Relative operating characteristic (ROC) curves used to compare drug screening immunoassays for amphetamine and methamphetamine. AACC ZD003: Clin. Chem. 35(6): 175 (1989).
15. J.A. Hanley and B.J. McNeil. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36 (1982).
16. D.A. Noe. Selecting a diagnostic study cutoff value by using its receiver operating characteristic curve. Clin. Chem. 29: 571-572 (1983).
17. J.R. Beck and E.K. Shultz. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch. Pathol. Lab. Med. 110: 13-20 (1986).
18. E.J. Cone, R. Lange, and W.D. Darwin. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results. J. Anal. Toxicol. 22: 460-473 (1998).
19. J.N. Wilkins. Quantitative urine levels of cocaine and other substances of abuse. NIDA Res. Monograph 175: 235-252 (1997).
20. P.C. Painter, J.H. Evans, J.D. Greenwood, and W.W. Fain. Urine cannabinoids monitoring. Diag. Clin. Testing 27: 29-33 (1989).
21. R. Bell, E.H. Taylor, B. Ackerman, and A.A. Pappas. Interpretation of urine quantitative 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking Clin. Toxicol. 27: 109-115 (1989).
22. P. Lafolie, O. Beck, G. Blennow, L. Boreus, S. Borg, C.E. Elwin, L. Karlsson, G. Odelius, and P. Hjemdahl. Importance of creatinine analyses of urine when screening for abused drugs. Clin. Chem. 37: 1927-1931 (1991).
23. R. Rodgers, C.P. Crowl, W.M. Eimstad, M.W. Hu, J.K. Kam, R.C. Ronald, G.L. Rowley, and E.F. Ullman. Homogeneous enzyme immunoassay for cannabinoids in urine. Clin. Chem. 24: 95-100 (1978).
24. 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J. Anal. Toxicol. 13: 218-223 (1989).
25. K.A. Haberny, S.L. Walsh, D.H. Ginn, J.N. Wilkins, J.E. Garner, D. Seloda, and G.E. Bigelow. Absence of acute cocaine interactions with the MAO-B inhibitor selegiline. Drug Alcohol Depend. 39: 55-62 (1995).
26. R.D. Weiss and F.H. Gawin. Protracted elimination of cocaine metaboilites in long-term, high-dose cocaine abusers. Am. J. Med. 85: 879-880 (1988).
27. S.G. Thompson, R.D. Barlow, N.J. Wald, and H.V. Vunakis. How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin. Chim. Acta 187: 289-296 (1990).
28. I.D. Watson. Analysis of commonly abused drugs in urine at selected threshold (cutoff) concentrations. Clin. Chem. 38(2): 441 (1992).
29. E.M. Gowans and C.G. Fraser. Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care. Ann. Clin. Biochem. 25: 259-263 (1988).
30. S.B. Needleman, M. Porvaznik, and D. Ander. Creatinine analysis in single collection urine specimens. J. Forensic Sci. 37: 1125-1133 (1992).
31. R. Swatek. Marijuana use: persistence and urinary elimination. J. Subst. Abuse Treat. 1: 265-270 (1984).
32. R.T. Jones. Cardiovascular effects of cannabinoids. In Marihuana '84. S.W. Paton and G.G. Nahas, Eds. IRL Press Limited, Oxford, U.K., 1985, pp 325-334.